NCT06144346View on ClinicalTrials.gov

Metastases Directed Therapy for Oligometastatic Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 20, 2023

Primary Completion Date

August 19, 2025

Study Completion Date

September 20, 2028

Conditions
Breast CancerMetastatic CancerMetastatic Breast Cancer
Interventions
RADIATION

Stereotactic Ablative Radiation Therapy

SABR to all metastatic lesions

PROCEDURE

Locoregional treatment

mastectomy or BCS for the primary tumor

OTHER

Standard of Care

Systemic treatment and palliative treatment

Trial Locations (1)

11796

RECRUITING

National Cancer Institute, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER